028300 - HLB Co., Ltd.

028300 Summary
Biopharma
Stock Price & Overview
₩33,750 +950 (+2.90%) Close · Sep 4, 2026 KST
KOSDAQ | ₩KRW | Close: ₩33,750  ≈ US$24  ·  Market cap ₩4.5tn (≈ $3.2bn)

Voluntary Disclosure — Other Management Matter

kstock has not written this one up. The title above is a translation of the Korean form name; the filing itself is on DART, in Korean.

Read the original on DART ↗ Korean. DART is Korea's electronic disclosure system, run by the Financial Supervisory Service — the filing equivalent of EDGAR.
Korean form name: 기타경영사항(자율공시) (HLB 간암 1차 치료제(리보세라닙,캄렐리주맙 병용요법)FDA로부터 보완요구서한(CRL,Complete Response Letter)수령)